(Q31795222)

English

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 July 2017

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole (English)

1 reference

Europe PubMed Central

3 July 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Hirschowitz BI

1

1 reference

Europe PubMed Central

3 July 2017

Haber MM

2

1 reference

Europe PubMed Central

3 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

3 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

3 July 2017

15

1 reference

Europe PubMed Central

3 July 2017

1

1 reference

Europe PubMed Central

3 July 2017

87-103

1 reference

Europe PubMed Central

3 July 2017

Prevalence of peptic ulcer in Helicobacter pylori positive blood donors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Risk factors associated with refractory peptic ulcers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Evidence of aspirin use in both upper and lower gastrointestinal perforation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Helicobacter pylori and Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Histopathological classification of nonantral gastric endocrine growths in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Long-term omeprazole therapy does not affect Helicobacter pylori status in most patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Gastrin is the most important factor in ECL tumorigenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Relationship between fundic endocrine cells and gastric acid secretion in hypersecretory duodenal ulcer diseases.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00876.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2001.00876.X

1 reference

Europe PubMed Central

3 July 2017

1 reference

Europe PubMed Central

3 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31795222&oldid=1965043283"